Open Demat
    Be a Partner
    Samadhan
    Install App
    Install App

    25718

    531768

    POLYMED

    img img img img
    Compare to down-arrow
    View down-arrow
    Display down-arrow
    Studies down-arrow
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    POLY MEDICURE LIMITED Share Price Today

    POLY MEDICURE LIMITED is currently trading at ₹1672.2, up by ₹8.19 from the previous close. The stock touched an intraday high of ₹1775.00 and a low of ₹1664.00 during the latest trading session. Over the past one year, POLY MEDICURE LIMITED has delivered a loss of 19.61%, while the stock has gained 0.79% in the last one month.

    POLY MEDICURE LIMITED performance

    Today’s low Today’s high
    ₹ 1664.00 ₹ 1775.00
    ₹ 1680.70
    52 week low 52 week high
    ₹ 1182.00 ₹ 2144.90
    ₹ 1680.70
    Open Price ₹ 1775.00
    Prev. Close ₹ 1664.00
    Volume (Shares) 148378.00
    Total traded value ₹ 2493.78
    Upper Circuit ₹ 1996.80
    Lower Circuit ₹ 1331.20
    info

    Investment Returns

    Over 1 Month 0.79% Over 3 Months 17.66% Over 6 Months 9.82% Over 1 Year -19.61%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    POLY MEDICURE LIMITED fundamentals


    • Market cap (Cr) 17,035.50
    • P/E Ratio (TTM) 50.27
    • Beta 0.90
    • Book Value / share 301.17
    • Return on equity 15.77%
    • EPS (TTM) 33.65
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 80.62
    info icon alternate text
    • Market cap (Cr) 17,024.80
    • P/E Ratio (TTM) 50.27
    • Beta 0.98
    • Book Value / share 301.17
    • Return on equity 15.77%
    • EPS (TTM) 33.65
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 80.62
    info icon alternate text

    POLY MEDICURE LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 443.01
    Operating Expense 351.33
    Net Profit 80.62
    Net Profit Margin (%) 18.19
    Earnings Per Share (EPS) 7.95
    EBITDA 136.21
    Effective Tax Rate (%) 24.51
    Particulars DEC 2025 (Values in Cr)
    Revenue 418.86
    Operating Expense 335.59
    Net Profit 78.38
    Net Profit Margin (%) 18.71
    Earnings Per Share (EPS) 7.73
    EBITDA 135.01
    Effective Tax Rate (%) 26.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 416.54
    Operating Expense 332.25
    Net Profit 89.05
    Net Profit Margin (%) 21.37
    Earnings Per Share (EPS) 8.79
    EBITDA 144.94
    Effective Tax Rate (%) 24.54
    Particulars JUN 2025 (Values in Cr)
    Revenue 384.05
    Operating Expense 308.50
    Net Profit 87.93
    Net Profit Margin (%) 22.89
    Earnings Per Share (EPS) 8.68
    EBITDA 142.71
    Effective Tax Rate (%) 24.89
    Particulars MAR 2025 (Values in Cr)
    Revenue 420.97
    Operating Expense 328.43
    Net Profit 86.66
    Net Profit Margin (%) 20.58
    Earnings Per Share (EPS) 8.40
    EBITDA 140.00
    Effective Tax Rate (%) 25.61
    Particulars MAR 2026 (Values in Cr)
    Revenue 1662.46
    Operating Expense 1327.68
    Net Profit 335.98
    Net Profit Margin (%) 20.20
    Earnings Per Share (EPS) 33.15
    EBITDA 559.22
    Effective Tax Rate (%) 24.98
    Particulars MAR 2025 (Values in Cr)
    Revenue 1601.80
    Operating Expense 1248.68
    Net Profit 331.33
    Net Profit Margin (%) 20.68
    Earnings Per Share (EPS) 33.40
    EBITDA 535.14
    Effective Tax Rate (%) 25.18
    Particulars MAR 2024 (Values in Cr)
    Revenue 1307.25
    Operating Expense 1030.53
    Net Profit 251.72
    Net Profit Margin (%) 19.25
    Earnings Per Share (EPS) 26.24
    EBITDA 407.20
    Effective Tax Rate (%) 24.83
    Particulars MAR 2023 (Values in Cr)
    Revenue 1068.05
    Operating Expense 867.50
    Net Profit 179.04
    Net Profit Margin (%) 16.76
    Earnings Per Share (EPS) 18.67
    EBITDA 300.77
    Effective Tax Rate (%) 24.39
    Particulars MAR 2022 (Values in Cr)
    Revenue 879.36
    Operating Expense 723.37
    Net Profit 146.02
    Net Profit Margin (%) 16.60
    Earnings Per Share (EPS) 15.23
    EBITDA 250.87
    Effective Tax Rate (%) 25.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 272.95
    ROE % 15.99
    ROCE % 20.24
    Total Debt to Total Equity 0.08
    EBITDA Margin 32.91
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 153.18
    ROE % 19.05
    ROCE % 23.44
    Total Debt to Total Equity 0.12
    EBITDA Margin 30.62
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 129.41
    ROE % 15.39
    ROCE % 18.95
    Total Debt to Total Equity 0.12
    EBITDA Margin 27.40
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 113.40
    ROE % 14.27
    ROCE % 17.26
    Total Debt to Total Equity 0.13
    EBITDA Margin 27.66
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 100.71
    ROE % 19.40
    ROCE % 21.67
    Total Debt to Total Equity 0.25
    EBITDA Margin 30.29
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 270.83
    ROE % 15.77
    ROCE % 20.03
    Total Debt to Total Equity 0.08
    EBITDA Margin 33.54
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 151.95
    ROE % 18.70
    ROCE % 23.12
    Total Debt to Total Equity 0.11
    EBITDA Margin 31.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 128.63
    ROE % 15.49
    ROCE % 19.21
    Total Debt to Total Equity 0.11
    EBITDA Margin 28.34
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 112.30
    ROE % 14.38
    ROCE % 17.54
    Total Debt to Total Equity 0.12
    EBITDA Margin 28.73
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 99.50
    ROE % 18.72
    ROCE % 21.37
    Total Debt to Total Equity 0.23
    EBITDA Margin 30.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 151.34
    Total Assets 3192.45
    Total Liabilities 3192.45
    Total Equity 2765.65
    Share Outstanding 10
    Price to Book Ratio 8.28
    Return on Assets (%) 10.60
    Return on Capital (%) 11.5
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 146.85
    Total Assets 1858.67
    Total Liabilities 1858.67
    Total Equity 1470.05
    Share Outstanding 9
    Price to Book Ratio 10.46
    Return on Assets (%) 13.89
    Return on Capital (%) 15.75
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 183.06
    Total Assets 1577.20
    Total Liabilities 1577.20
    Total Equity 1241.62
    Share Outstanding 9
    Price to Book Ratio 7.41
    Return on Assets (%) 11.36
    Return on Capital (%) 12.92
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 15.43
    Total Assets 1376.83
    Total Liabilities 1376.83
    Total Equity 1087.48
    Share Outstanding 9
    Price to Book Ratio 8.45
    Return on Assets (%) 10.64
    Return on Capital (%) 12.08
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 29.56
    Total Assets 1223.73
    Total Liabilities 1223.73
    Total Equity 965.57
    Share Outstanding 9
    Price to Book Ratio 8.22
    Return on Assets (%) 11.10
    Return on Capital (%) 12.36
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 143.19
    Total Assets 3140.35
    Total Liabilities 3140.35
    Total Equity 2744.21
    Share Outstanding 10
    Price to Book Ratio 8.28
    Return on Assets (%) 10.55
    Return on Capital (%) 11.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 136.94
    Total Assets 1821.34
    Total Liabilities 1821.34
    Total Equity 1458.24
    Share Outstanding 9
    Price to Book Ratio 10.46
    Return on Assets (%) 13.82
    Return on Capital (%) 15.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 170.95
    Total Assets 1537.76
    Total Liabilities 1537.76
    Total Equity 1234.12
    Share Outstanding 9
    Price to Book Ratio 7.41
    Return on Assets (%) 11.64
    Return on Capital (%) 13.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.31
    Total Assets 1333.96
    Total Liabilities 1333.96
    Total Equity 1076.97
    Share Outstanding 9
    Price to Book Ratio 8.45
    Return on Assets (%) 10.94
    Return on Capital (%) 12.31
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 27.40
    Total Assets 1187.41
    Total Liabilities 1187.41
    Total Equity 954.00
    Share Outstanding 9
    Price to Book Ratio 8.22
    Return on Assets (%) 10.90
    Return on Capital (%) 12.4
    Particulars MAR 2025 (Values in Cr)
    Net Income 452.51
    Cash from Operations 332.83
    Cash from Investing -1194.27
    Cash from Financing 950.50
    Net change in Cash -3.35
    Free Cash Flow 663.85
    Particulars MAR 2024 (Values in Cr)
    Net Income 344.26
    Cash from Operations 340.38
    Cash from Investing -240.93
    Cash from Financing -20.15
    Net change in Cash 4.99
    Free Cash Flow 617.39
    Particulars MAR 2023 (Values in Cr)
    Net Income 237.49
    Cash from Operations 248.69
    Cash from Investing -179.01
    Cash from Financing -12.50
    Net change in Cash -0.69
    Free Cash Flow 487.96
    Particulars MAR 2022 (Values in Cr)
    Net Income 195.24
    Cash from Operations 170.92
    Cash from Investing -85.33
    Cash from Financing -35.33
    Net change in Cash 2.80
    Free Cash Flow 326.50
    Particulars MAR 2021 (Values in Cr)
    Net Income 180.05
    Cash from Operations 163.35
    Cash from Investing -435.58
    Cash from Financing 316.94
    Net change in Cash 0.09
    Free Cash Flow 258.48
    Particulars MAR 2025 (Values in Cr)
    Net Income 442.89
    Cash from Operations 325.66
    Cash from Investing -1191.16
    Cash from Financing 952.92
    Net change in Cash -1.59
    Free Cash Flow 650.65
    Particulars MAR 2024 (Values in Cr)
    Net Income 334.89
    Cash from Operations 329.84
    Cash from Investing -237.02
    Cash from Financing -17.31
    Net change in Cash 1.76
    Free Cash Flow 601.23
    Particulars MAR 2023 (Values in Cr)
    Net Income 236.82
    Cash from Operations 254.66
    Cash from Investing -189.18
    Cash from Financing -7.89
    Net change in Cash -0.25
    Free Cash Flow 492.12
    Particulars MAR 2022 (Values in Cr)
    Net Income 194.71
    Cash from Operations 173.12
    Cash from Investing -88.71
    Cash from Financing -39.71
    Net change in Cash -2.16
    Free Cash Flow 324.93
    Particulars MAR 2021 (Values in Cr)
    Net Income 173.38
    Cash from Operations 160.53
    Cash from Investing -434.41
    Cash from Financing 318.91
    Net change in Cash 0.90
    Free Cash Flow 254.49
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8804.30 64.71 13.36 126592.33 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.53 22.86 2.75 94.70 40.75 76.00
    SHREE PACETRONIX LTD. 128.05 15.28 2.69 48.01 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.04 0.00 2.74 23.03 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8804.30 84.32 12.70 126592.33 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.30 0.00 -9.07 27.86 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 5848.30 26.17 4.84 6398.04 5010.00 6725.00

    POLY MEDICURE LIMITED shareholding pattern

    Holding
    15.93%
    62.41%
    5.56%
    16.07%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    POLY MEDICURE LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1680.70 1.00 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 1668.40
    • 26 Days 1644.30
    • 10 Days 1672.90
    • 50 Days 1596.80
    • 12 Days 1671.70
    • 100 Days 1570.70
    • 20 Days 1657.90
    • 200 Days 1653.50
    1650.37 PIVOT
    First Support 1624.73 First Resistance 1689.63 Second Support 1585.47 Second Resistance 1715.27 Third Support 1559.83 Third Resistance 1754.53
    RSI 52.66 ADX 44.63 MACD 27.39 Williams % R -65.51 Commodity Channel Index (CCI) -78.50
    Date 2026-07-24 Week 40683.00 Same Day 20551.00 Month 49964.00
    1 Year 0.91 3 Year 0.80
    Over 1 Month
    0.79% down
    Over 1 Year
    -19.61% down
    Over 3 Months
    17.66% down
    Over 3 Years
    13.26% down
    Over 6 Months
    9.82% down
    Over 5 Years
    10.36% down

    POLY MEDICURE LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
    21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
    16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
    16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
    27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
    13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
    15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
    11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
    19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
    17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
    18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
    15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
    19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
    24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
    21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
    23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
    06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Mar 2017 24 Mar 2017 1:1
    10 Jul 2013 09 Jul 2013 1:1
    29 Mar 2010 26 Mar 2010 1:1
    Ex-Date Old FV NEW FV Record Date
    02 Feb 2015 10.0 5.0 03 Feb 2015
    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    19 Sep 2024 3.0 Final 20 Sep 2024 Equity shares
    21 Sep 2023 3.0 Final 22 Sep 2023 Equity shares
    16 Sep 2022 2.5 Final 19 Sep 2022 Equity shares
    16 Sep 2021 2.5 Final 17 Sep 2021 Equity shares
    27 Feb 2020 2.0 Interim 29 Feb 2020 Equity shares
    13 Sep 2019 2.0 Final 17 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    20 Sep 2017 0.5 Final 22 Sep 2017 Equity shares
    15 Feb 2017 1.0 Interim 2 16 Feb 2017 Equity shares
    11 Nov 2016 1.0 Interim 15 Nov 2016 Equity shares
    19 Sep 2016 0.5 Final 21 Sep 2016 Equity shares
    17 Mar 2016 2.5 Interim 18 Mar 2016 Equity shares
    18 Sep 2015 2.5 Final 22 Sep 2015 Equity shares
    15 Sep 2014 4.0 Final 17 Sep 2014 Equity shares
    19 Sep 2013 2.0 Final 23 Sep 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    25 Aug 2011 3.0 Final 27 Aug 2011 Equity shares
    24 Aug 2010 2.5 Final 26 Aug 2010 Equity shares
    21 Aug 2009 2.5 Final 25 Aug 2009 Equity shares
    23 Aug 2007 2.5 Final 27 Aug 2007 Equity shares
    06 Sep 2005 0.0 Final 09 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Mar 2017 24 Mar 2017 1:1
    10 Jul 2013 09 Jul 2013 1:1
    29 Mar 2010 26 Mar 2010 1:1
    Ex-Date Old FV NEW FV Record Date
    02 Feb 2015 10.0 5.0 03 Feb 2015

    Top Gainers

    up-arrow (%)

    Top Losers

    up-arrow (%)
    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Devendra Raj Mehta Chairman(Non Exe)&Dir(Non-Ind)
    Himanshu Baid Executive Director & MD
    Jugal Kishore Baid Non Executive Director
    Rishi Baid Joint MD & Executive Director
    Alessandro Balboni Non-Exec & Non-Independent Dir
    Amit Khosla Independent Non Exe. Director
    Sonal Mattoo Independent Non Exe. Director
    Ambrish Mithal Independent Non Exe. Director
    Vimal Bhandari Independent Non Exe. Director
    Vishal Gupta Independent Non Exe. Director
    Avinash Chandra Company Sec. & Compli. Officer

    Similar stocks

    similar-logo APOLLOHOSP
    0.43%
    8843.5 38.00
    down-arrow
    similar-logo MAXHEALTH
    3.16%
    1114.6 34.19
    down-arrow
    similar-logo FORTIS
    -0.67%
    942.3 -6.40
    down-arrow
    similar-logo ASTERDM
    2.01%
    801.5 15.84
    down-arrow
    similar-logo NH
    4.71%
    2054 92.50
    down-arrow
    similar-logo MEDANTA
    2.91%
    1411 40.00
    down-arrow
    similar-logo KIMS
    0.32%
    800.45 2.60
    down-arrow
    similar-logo LALPATHLAB
    3.86%
    1827.2 68.00
    down-arrow
    similar-logo SYNGENE
    1.77%
    413.85 7.20
    down-arrow
    similar-logo AGARWALEYE
    -1.41%
    472.1 -6.79
    down-arrow

    Frequently Asked Questions

    What is the Current Share Price of Poly Medicure Ltd?

    Answer Field

    Poly Medicure Ltd share price is for NSE ₹ 1,672.20 & for BSE ₹ 1,680.00 as on Jul 27 2026 03:29 PM.

    What is the Market Cap of Poly Medicure Ltd Share?

    Answer Field

    The market cap of Poly Medicure Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 27 2026 03:29 PM.

    What is the 52 Week High and Low of Poly Medicure Ltd?

    Answer Field

    The 52 Week High and Low of Poly Medicure Ltd for NSE is ₹ 2,144.90 and ₹ 1,182.00 and for BSE is ₹ 2,143.60 and ₹ 1,184.00.

    What is 1 year return for Poly Medicure Ltd?

    Answer Field

    The 1 year returns on the stock has been -19.61%.

    What is the P/E Ratio of Poly Medicure Ltd Share?

    Answer Field

    As on Jul 27 2026 03:29 PM the price-to-earnings (PE) ratio for Poly Medicure Ltd share is 50.27.

    What is the PB ratio of Poly Medicure Ltd Share?

    Answer Field

    As on Jul 27 2026 03:29 PM, the price-to-book (PB) ratio for Poly Medicure Ltd share is 301.17.

    How to Buy Poly Medicure Ltd Share?

    Answer Field

    You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Poly Medicure Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Poly Medicure Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Poly Medicure Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Products

    arrow

    Calculators

    arrow

    Mutual Funds & SIP

    arrow

    Important Links

    arrow

    Explore

    arrow

    Corporate

    arrow

    Discover

    arrow

    Popular Stocks

    arrow

    Indian Indices

    arrow

    Global Indices

    arrow

    Sector Wise Stocks

    arrow

    IPO

    arrow

    ATTENTION INVESTORS:

    “Investments in securities market are subject to market risk, read all the scheme related documents carefully before investing."

    "Prevent Unauthorized transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/ Demat Account directly from Exchange/CDSL/NSDL at the end of the day. Issued in the interest of investors."

    " We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services."  

    "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

    "We understand that certain investment advisors may be approaching members of the public including our clients, representing that they are our partners, or representing that their investment advice is based on our research. Please note that we have not engaged any third parties to render any investment advisory services on our behalf nor are we providing any stock recommendations/tips/research report/advisory. Persons making investments on the basis of such advice may lose all or a part of their investments along with the fee paid to such unscrupulous persons. Please be cautious about any phone call that you may receive from persons representing to be such investment advisors, or a part of research firm offering advice on securities. Do not make payments through e-mail links, WhatsApp or SMS. Please do not share your personal or financial information with any person without proper verification. Always trade through a registered broker."

    Bajaj Financial Securities Limited is a subsidiary of Bajaj Finance Limited and is a corporate trading and clearing member of BSE Ltd. and National Stock Exchange of India Ltd. (NSEIL), and also a Depository participant with National Securities Depository Ltd (“NSDL”) and Central Depository Services Ltd. (“CDSL”).

    Bajaj Financial Securities Limited is engaged in the business of Stock Broking and as a Depository Participant.Bajaj Financial Securities Limited does not provide any advisory services to its clients. Bajaj Financial Securities Limited may share updates from time to time (through various electronic communication modes) which are sourced from public domain and the same are NOT to be construed as any advice or recommendation from Bajaj Financial Securities Limited. Client is requested to independently evaluate and/or consult their professional advisors before arriving at any conclusion to make any investment. The decision to invest shall be the sole responsibility of the Client and shall not hold Bajaj Financial Securities Limited, its employees and associates responsible for any losses, damages of any type whatsoever.

    BSE Ltd. is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time.

    BSE Ltd. is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.

    Personal Loan, Fixed Deposit, EMI Card are provided by Bajaj Finance Limited. Bajaj Financial Securities Limited is only a distributor. These are not exchange traded products and all disputes with respect to the distribution activity, would not have access to exchange investor redressal forum or Arbitration mechanism.

    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

    Please Note:

    1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

    2. Update your mobile number & email ID with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

    3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

    4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard.

    5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in Vernacular Language: BSE | NSE

    If the client wishes to revoke /cancel the EDIS mandate placed by them, they can write on email us or call on the toll free number.

    Advisory for Investors : NSE | BSE

    We also do pro-account trading in Equity & Derivatives Segment.

    Filling complaints on SCORES/SMARTODR Portal - Easy & Quick

    A.  Register on SCORES/SMARTODR portal B. Mandatory details for filling complaints on SCORES/SMARTODR:(Name, PAN, Address, Mobile Number, Email ID) C. Benefits: (i) Effective Communication (ii) Speedy redressal of the grievances / Dispute.

    SEBI Registration No.: INZ000218931 | BSE Cash/CDS/F&O (Member ID: 6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No : IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN – 163403 Research Analyst SEBI Registration No. INH000010043

    Compliance officer:

    Mr. Harinatha Reddy Muthumula
    TEL: 020-48574486
    Email for any investor grievances or write to us for DP related matters.

    DISCLAIMER

    STANDARD DISCLAIMER

    Investments in the securities market are subject to market risk, read all related documents carefully before investing.

    Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403. 

    Website: Bajaj Broking

    RESEARCH DISCLAIMER

    Broking services offered by Bajaj Financial Securities Limited | Registered Office: Bajaj Auto Limited Complex , Mumbai –Pune Road Akurdi Pune 411035 | Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014 | CIN: U67120PN2010PLC136026 | Research Analyst SEB I Registration No: INH000010043.

    Details of Compliance Officer: 

    Mr. Harinatha Reddy Muthumula  (For Broking/DP/Research)
    Email | Contact No.: 020-4857 4486 

    Investment in the securities involves risks, investor should consult his own advisors/consultant to determine the merits and risks of investment.

    DISCLOSURES

    Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) 

    Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed byBajaj Financial Securities Limited in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No. INH000010043. 

    DISCLAIMER

    This e-mail/ short message service (SMS) may contain confidential, proprietary or legally privileged information. It should not be used by anyone who is not the original intended recipient. If you have erroneously received this message, please delete it immediately and notify the sender. The recipient acknowledges thatBajaj Financial Securities Limited or its holding and/or associated companies, as the case may be, are unable to exercise control or ensure or guarantee the integrity of/over the contents of the information contained in e-mail /SMS transmissions and further acknowledges that any views expressed in this message are those of the individual sender and no binding nature of the message shall be implied or assumed unless the sender does so expressly with due authority of Bajaj Financial Securities Limited. This message is not intended as an offer or publication or solicitation for distribution for subscription of or purchase or sale of any securities or financial instrument(s) to anyone in whose jurisdiction such subscription etc. requires prior local regulatory clearance or is contrary to the local laws of the land in any manner or as an official confirmation of any transaction. Before opening any attachments, please check them for viruses and defects. 

    This service / information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose unless otherwise expressly authorised. This service / information is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subjectBajaj Financial Securities Limited and affiliates/ group/holding companies to any registration or licensing requirements within such jurisdiction. The distribution of this document in certain jurisdictions may be restricted by law, and persons in whose possession this document comes, should inform themselves about and observe any such restrictions.  

    The data would be provided to the clients on an "as is" and "where-is" basis, without any warranty. Bajaj Financial Securities Limited or its subsidiaries and associated companies shall not be liable for any delay or any other interruption which may occur in providing the data due to any reason including network (Internet) reasons or snags in the system, breakdown of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the Bajaj Financial Securities Limited or its subsidiaries and associated companies to provide the data. In no event shall the Bajaj Financial Securities Limited or its holding and associated companies be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data provided by the Bajaj Financial Securities Limited or its holding and associated companies.

    ADDITIONAL DISCLAIMER FOR U.S. PERSONS

    Bajaj Financial Securities Limited is not a registered broker-dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition, Bajaj Financial Securities Limited is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for U.S. persons. This email message does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules.  

    ADDITIONAL DISCLAIMER FOR CANADIAN PERSONS

    Bajaj Financial Securities Limited is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for Canadian persons.  

    This mailer and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services.  

    DISCLAIMER FOR REPORT

    DISCLOSURES UNDER THE PROVISIONS OF SEBI (RESEARCH ANALYSTS) REGULATIONS 2014 (REGULATIONS)

    Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities.  

    This Report has been prepared by Bajaj Financial Securities Limited in the capacity of a Research Analyst having SEBI Registration No. INH000010043 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors.  

    This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Bajaj Financial Securities Limited and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. Bajaj Financial Securities Limited reserves the right to make modifications and alterations to this statement as may be required from time to time. Bajaj Financial Securities Limited or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Bajaj Financial Securities Limited is committed to providing independent and transparent recommendation to its clients. Neither Bajaj Financial Securities Limited nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance .The disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of Bajaj Financial Securities Limited. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of Bajaj Financial Securities Limited and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders.  

    We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report.  

    Bajaj Financial Securities Limited and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Bajaj Financial Securities Limited may have proprietary long/short position in the above-mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with Bajaj Financial Securities Limited.  

    Bajaj Financial Securities Limited or its associates may have received compensation from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or Bajaj Financial Securities Limited’s associates may have financial interest in the subject company. Bajaj Financial Securities Limited, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance.  

    Research analyst has served as an officer, director or employee of subject Company: No  

    Bajaj Financial Securities Limited has financial interest in the subject companies: No  

    Bajaj Financial Securities Limited’s Associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report.  

    Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

    Bajaj Financial Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

    Subject company may have been client during twelve months preceding the date of distribution of the research report.  

    There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at NSE

    ANALYST CERTIFICATION

    The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.  

    RISK DISCLOSURE ON DERIVATIVES

    • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    • On an average, loss makers registered net trading loss close to ₹ 50,000.
    • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

    SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

    BROKERAGE DISCLAIMER

    All leveraged intraday positions will be squared off on the same day. There is no restriction on the withdrawal of the unutilised margin amount. Brokerage will not exceed the SEBI prescribed limit. Visit : Pricing

    MTF 

    As subject to the provisions of SEBI Circular CIR/MRD/DP/54/2017 dated June 13, 2017, and the terms and conditions mentioned in the lights and obligations statement issued by the TM (if applicable).  

    US INVESTING

    International investment is not supervised by any regulatory body in India. Thus, any claim or dispute relating to such investment or enforcement of any agreement/contract /claim will not be under laws and regulations of the recognized stock exchanges and investor protection under Indian Securities Law. The account opening process will be carried out on Vested platform and Bajaj Financial Securities Limited will not have any role in it.  

    IPO 

    This should not be construed as soliciting investment. Investors’ discretion is required. Kindly consult your financial expert before investing. No need to issue cheques by investors while subscribing to IPO. Investments in securities markets are subject to market risks, read all the related documents carefully before investing.  

    SCREENERS 

    Screeners is not Exchange-approved products and any disputes related to the same will not be dealt on the Exchange platform. 

    SECURITIES 

    Securities quoted are exemplary and not recommendatory. 

    IPV 

    Account would be open after all procedure relating to IPV and client due diligence is completed. 

    IMAGES 

    The images used are only for representation purpose. Proper due diligence has been done for the images and the image is not of any artist. The same is captured from royalty free sites.

    THIRD PARTY PRODUCT DISCLAIMER

    Bajaj Financial Securities Limited is a distributor for Non-Broking Products/Services such as Mutual Funds, Mutual Funds SIP, IPO, Bonds, Insurance, PMS, Global Investing, any other third-party products/services. These are not Exchange Traded Products, and we are only acting as distributors. All disputes with respect to the distribution activity, would not have access to SCORES/ODR, Exchange investor redressal forum or Arbitration mechanism. Please refer to the detailed disclaimer for Third-Party Products.

    DISCLOSURE TO CLIENTS REGARDING PAYOUT OF FUNDS

    As per SEBI circular no. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/84 dated June 08, 2023, Stockbrokers are required to upstream the entire client funds lying with them to the Clearing Corporation. Based on client’s request the funds’ release request must be placed with the Clearing Corporation. Based on the internal process and cut-off timelines of the Clearing Corporation the funds will be released to the Stock Broker. In view of this new process, as specified by the regulatory and the cut-off time of Clearing Corporation/Banks processing the funds, Bajaj Financial Securities Limited cannot commit the exact time for releasing funds payout to its client. Clients are requested to note that, Bajaj Financial Securities Limited will not be responsible for any inconvenience caused to clients due to delay in release of funds payout, including fines, delayed charges, defaults, etc.